144 related articles for article (PubMed ID: 27566229)
1. GLP-1 analogue recovers impaired insulin secretion from human islets treated with palmitate via down-regulation of SOCS2.
Chowdhury AI; Bergsten P
Mol Cell Endocrinol; 2017 Jan; 439():194-202. PubMed ID: 27566229
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Exposure of Pancreatic β-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response.
Natalicchio A; Biondi G; Marrano N; Labarbuta R; Tortosa F; Spagnuolo R; D'Oria R; Carchia E; Leonardini A; Cignarelli A; Perrini S; Laviola L; Giorgino F
Endocrinology; 2016 Jun; 157(6):2243-58. PubMed ID: 27035653
[TBL] [Abstract][Full Text] [Related]
3. Repression of sterol regulatory element-binding protein 1-c is involved in the protective effects of exendin-4 in pancreatic β-cell line.
Hong SW; Lee J; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Lee WY
Mol Cell Endocrinol; 2012 Oct; 362(1-2):242-52. PubMed ID: 22820130
[TBL] [Abstract][Full Text] [Related]
4. Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line.
Wei Q; Sun YQ; Zhang J
Peptides; 2012 Sep; 37(1):18-24. PubMed ID: 22776329
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 and islet lipolysis.
Sörhede Winzell M; Ahrén B
Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
[TBL] [Abstract][Full Text] [Related]
6. Durable islet effects on insulin secretion and protein kinase A expression following exendin-4 treatment of high-fat diet-fed mice.
Winzell MS; Ahrén B
J Mol Endocrinol; 2008 Feb; 40(2):93-100. PubMed ID: 18234911
[TBL] [Abstract][Full Text] [Related]
7. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
[TBL] [Abstract][Full Text] [Related]
8. High glucose induces suppression of insulin signalling and apoptosis via upregulation of endogenous IL-1beta and suppressor of cytokine signalling-1 in mouse pancreatic beta cells.
Venieratos PD; Drossopoulou GI; Kapodistria KD; Tsilibary EC; Kitsiou PV
Cell Signal; 2010 May; 22(5):791-800. PubMed ID: 20067833
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 induced signaling and insulin secretion do not drive fuel and energy metabolism in primary rodent pancreatic beta-cells.
Peyot ML; Gray JP; Lamontagne J; Smith PJ; Holz GG; Madiraju SR; Prentki M; Heart E
PLoS One; 2009 Jul; 4(7):e6221. PubMed ID: 19593440
[TBL] [Abstract][Full Text] [Related]
10. FFAR1 is involved in both the acute and chronic effects of palmitate on insulin secretion.
Kristinsson H; Smith DM; Bergsten P; Sargsyan E
Endocrinology; 2013 Nov; 154(11):4078-88. PubMed ID: 24035997
[TBL] [Abstract][Full Text] [Related]
11. The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways.
Favaro E; Granata R; Miceli I; Baragli A; Settanni F; Cavallo Perin P; Ghigo E; Camussi G; Zanone MM
Diabetologia; 2012 Apr; 55(4):1058-70. PubMed ID: 22231124
[TBL] [Abstract][Full Text] [Related]
12. Involvement of phosphatidylinositol-3 kinase/AKT/PKCzeta/lambda pathway in the effect of palmitate on glucose-induced insulin secretion.
Nogueira TC; Anhê GF; Carvalho CR; Curi R; Bordin S; Carpinelli AR
Pancreas; 2008 Oct; 37(3):309-15. PubMed ID: 18815554
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.
Farilla L; Bulotta A; Hirshberg B; Li Calzi S; Khoury N; Noushmehr H; Bertolotto C; Di Mario U; Harlan DM; Perfetti R
Endocrinology; 2003 Dec; 144(12):5149-58. PubMed ID: 12960095
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
[TBL] [Abstract][Full Text] [Related]
15. Palmitate-Induced Insulin Hypersecretion and Later Secretory Decline Associated with Changes in Protein Expression Patterns in Human Pancreatic Islets.
Groebe K; Cen J; Schvartz D; Sargsyan E; Chowdhury A; Roomp K; Schneider R; Alderborn A; Sanchez JC; Bergsten P
J Proteome Res; 2018 Nov; 17(11):3824-3836. PubMed ID: 30183308
[TBL] [Abstract][Full Text] [Related]
16. Evidence for paracrine/autocrine regulation of GLP-1-producing cells.
Kappe C; Zhang Q; Holst JJ; Nyström T; Sjöholm A
Am J Physiol Cell Physiol; 2013 Nov; 305(10):C1041-9. PubMed ID: 23986202
[TBL] [Abstract][Full Text] [Related]
17. The suppressor of cytokine signalling 2 (SOCS2) is a key repressor of insulin secretion.
Lebrun P; Cognard E; Gontard P; Bellon-Paul R; Filloux C; Berthault MF; Magnan C; Ruberte J; Luppo M; Pujol A; Pachera N; Herchuelz A; Bosch F; Van Obberghen E
Diabetologia; 2010 Sep; 53(9):1935-46. PubMed ID: 20499047
[TBL] [Abstract][Full Text] [Related]
18. Impaired cAMP generation contributes to defective glucose-stimulated insulin secretion after long-term exposure to palmitate.
Tian G; Sol ER; Xu Y; Shuai H; Tengholm A
Diabetes; 2015 Mar; 64(3):904-15. PubMed ID: 25281428
[TBL] [Abstract][Full Text] [Related]
19. Calcium/calmodulin-dependent serine protein kinase is involved in exendin-4-induced insulin secretion in INS-1 cells.
Zhu ZQ; Wang D; Xiang D; Yuan YX; Wang Y
Metabolism; 2014 Jan; 63(1):120-6. PubMed ID: 24140090
[TBL] [Abstract][Full Text] [Related]
20. Addition of exogenous sodium palmitate increases the IAPP/insulin mRNA ratio via GPR40 in human EndoC-βH1 cells.
Krizhanovskii C; Fred RG; Oskarsson ME; Westermark GT; Welsh N
Ups J Med Sci; 2017 Aug; 122(3):149-159. PubMed ID: 28980863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
